<!doctype html>
<html lang="en">
  <head>
    <!-- Title and description ================================================== -->
    
              <meta name="csrf-param" content="authenticity_token">
              <meta name="csrf-token" content="DN2saX+GnJF9dKMOsMnzUSPOjJ5GFSrAKuiKSiq87wqwFzArV3CZwok14oCJeRewPsQziT67hLJv1fWkNcM+mw==">
            
    <title>
      
        Moby | Become a smarter investor in just 5 minutes
      
    </title>
    <meta charset="utf-8" />
    <meta content="IE=edge,chrome=1" http-equiv="X-UA-Compatible">
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no">
    
      <meta name="description" content="We send you daily investing strategies, stock research, and crypto analysis that&#39;s fun to read and easy to digest. Join today for free and start making smarter investing decisions." />
    

    <!-- Helpers ================================================== -->
    
    
      <link href="https://kajabi-storefronts-production.kajabi-cdn.com/kajabi-storefronts-production/themes/2148837788/settings_images/cT6NmsumSriMG1LbzqFR_Untitled_design_17.png?v=2" rel="shortcut icon" />
    
    <link rel="canonical" href="2151894411.html" />

    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.5.0/css/all.css" integrity="sha384-B4dIYHKNBt8Bc12p+WXckhzcICo0wtJAoU8YZTY5qE0Id1GSseTk6S+L3BlXeVIU" crossorigin="anonymous">


    <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.1.3/css/bootstrap.min.css" integrity="sha384-MCw98/SFnGE8fJT3GXwEOngsV7Zt27NXFoaoApmYm81iuXoPkFOJwJ8ERdknLPMO" crossorigin="anonymous">
    
      <link href="https://fonts.googleapis.com/css?family=Poppins:400,700,400italic,700italic" rel="stylesheet" type="text/css">
    
    <link rel="stylesheet" media="screen" href="https://kajabi-app-assets.kajabi-cdn.com/assets/core-8cc7151051efbc8322c251aae2b556b928bcd0ebfc79f909c1f847eed9932b7f.css" />
    <link rel="stylesheet" media="screen" href="https://kajabi-storefronts-production.kajabi-cdn.com/kajabi-storefronts-production/themes/2148837788/assets/styles.css?1634851986331554" />

    <!-- Header hook ================================================== -->
    <script type="text/javascript">
  var Kajabi = Kajabi || {};
</script>
<script type="text/javascript">
  Kajabi.currentSiteUser = {
    "id" : "2160609026",
    "type" : "Member"
  };
</script>
<script type="text/javascript">
  Kajabi.theme = {
    activeThemeName: "Production Live",
    previewThemeId: null,
    editor: false
  };
</script>
<script>
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)
},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
})(window,document,'script','//www.google-analytics.com/analytics.js','ga');

ga('create', 'UA-199580424-1', 'auto', {"userId":2202749271});
ga('send', 'pageview');
</script>
<style type="text/css">
  #editor-overlay {
    display: none;
    border-color: #2E91FC;
    position: absolute;
    background-color: rgba(46,145,252,0.05);
    border-style: dashed;
    border-width: 3px;
    border-radius: 3px;
    pointer-events: none;
    cursor: pointer;
    z-index: 10000000000;
  }
  .editor-overlay-button {
    color: white;
    background: #2E91FC;
    border-radius: 2px;
    font-size: 13px;
    margin-left: -24px;
    margin-top: -12px;
    padding: 3px 10px;
    text-transform:uppercase;
    font-weight:bold;
    letter-spacing:1.5px;

    left: 50%;
    top: 50%;
    position: absolute;
  }
</style>
<script>
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;
n.push=n;n.loaded=!0;n.version='2.0';n.agent='plkajabi';n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
                                                                      document,'script','https://connect.facebook.net/en_US/fbevents.js');

fbq('init', '664252340905038', {"ct":null,"country":null,"em":"ilya.ek@gmail.com","fn":"Ilya","ln":"Kiselev","pn":null,"zp":null});
fbq('track', "PageView");</script>
<noscript><img height="1" width="1" style="display:none"
src="https://www.facebook.com/tr?id=664252340905038&ev=PageView&noscript=1"
/></noscript>
<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-5SBLJRW');</script>
<!-- End Google Tag Manager --><meta name='site_locale' content='en'>
  </head>
  <body class="d-flex flex-fill">

    <div class="main-sidebar col flex-fill">
  <div id="section-mini_dashboard" data-section-id="mini_dashboard">














<div class="mini-dashboard">
  <a href="../../../../premium-investing-research.1.html" class="mini-dashboard-back" kjb-settings-id="sections_mini_dashboard_settings_dashboard">
    <i class="fas fa-chevron-left"></i>
    Dashboard
  </a>
  <h1 class="mini-dashboard-title">Premium Investing Research</h1>
  <div class="media">
    <div class="mr align-self-center">
      <div class="avatar avatar-sm avatar-light avatar-1">
        <img class="avatar-img" src="https://www.gravatar.com/avatar/df42ea502a25d65db01cfd5e62d26643?s=42&d=https://s3.amazonaws.com/kajabi-storefronts-production/static_assets/default_avatar.jpg"/>
      </div>
    </div>
    <div class="media-body">
      <h5 class="mini-dashboard-user">Ilya Kiselev</h5>
      <div class="mini-dashboard-completion" kjb-settings-id="sections_mini_dashboard_settings_complete">1% Complete</div>
    </div>
  </div>
</div>

</div>
  <div id="section-product_outline" data-section-id="product_outline">

<div class="product-outline">
  
    
      <h3 class="product-outline-category"><a href="../../2148695518.html">Investing Strategies</a></h3>
      
      
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148695519.1.html">Information Technology</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148695520.1.html">Consumer Discretionary</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721378.1.html">Industrials</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721389.1.html">Financials</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721380.1.html">Health Care</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721417.1.html">Communication Services</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721435.1.html">Energy</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721471.html">Real Estate</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721438.html">Materials</a></h3>
            
          
        
      
    
  
    
      <h3 class="product-outline-category"><a href="../../2148737584.1.html">Crypto</a></h3>
      
      
    
  
    
      <h3 class="product-outline-category"><a href="../../2148721319.1.html">Market & Industry Analysis</a></h3>
      
      
    
  
    
      <h3 class="product-outline-category"><a href="../../2148721346.1.html">Rankings and Lists</a></h3>
      
      
    
  
    
      <h3 class="product-outline-category"><a href="../../2148721443.1.html">Hedge Fund Holdings</a></h3>
      
      
    
  
    
      <h3 class="product-outline-category"><a href="../../2148721457.1.html">Portfolio Strategy</a></h3>
      
      
    
  
</div>
</div>
</div>
<div class="main-content col flex-fill">
  





<div class="responsive-toggle">
  <div class="media">
    <div class="align-self-center"><i class="responsive-toggle-trigger fas fa-bars"></i></div>
    <div class="align-self-center media-body">
      
        <form action="https://www.moby.co/products/premium-investing-research/search" method="get" role="search">
          <div class="input-group search" kjb-settings-id="show_search">
            <div class="input-group-prepend">
              <div class="input-group-text search-icon"><i class="fa fa-search"></i></div>
            </div>
            <input class="form-control search-input" type="search" name="q" placeholder="Search for something..." kjb-settings-id="search_text">
          </div>
        </form>
      
    </div>
  </div>
</div>

  






  <form action="https://www.moby.co/products/premium-investing-research/search" method="get" role="search">
    <div class="input-group search post-page" kjb-settings-id="show_search">
      <div class="input-group-prepend">
        <div class="input-group-text search-icon"><i class="fa fa-search"></i></div>
      </div>
      <input class="form-control search-input" type="search" name="q" placeholder="Search for something..." kjb-settings-id="search_text">
    </div>
  </form>


  





  <div id="section-post_actions" data-section-id="post_actions">















<div class="post-actions" kjb-settings-id="sections_post_actions_settings_downloads">
  <div class="media align-items-center">
    <div class="post-actions-pagination">
      
        <a href="2151894392.html">
          <i class="fas fa-angle-left"></i>
        </a>
      
    </div>
    <div class="media-body">
      <div class="post-actions-container">
        <div class="media align-items-center">
          <div class="media-body">
            
            

          </div>
          <div>
            <a href="2151894411.html#" data-favorite-toggle="true" data-favorited="false" data-favorite-token="BAh7CEkiCGdpZAY6BkVUSSIpZ2lkOi8va2FqYWJpLXBvcnRhbHMvUG9zdC8yMTUxODk0NDExBjsAVEkiDHB1cnBvc2UGOwBUSSIOZmF2b3JpdGVzBjsAVEkiD2V4cGlyZXNfYXQGOwBUSSIdMjAyMS0xMS0yM1QxNjo1NDoxOS45MzZaBjsAVA==--aa485d94b1165ac1cf350e58922191d144050a2d" class="post-actions-favorite ">
              <i class="far fa-star"></i>
            </a>
          </div>
          <div>
            <a href="2151894411.html#" data-complete-text="Mark As Read" data-incomplete-text="Read" data-post-completion-toggle="false" data-token="eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJhY3Rvcl90eXBlIjoiTWVtYmVyIiwiYWN0b3JfaWQiOjIxNjA2MDkwMjYsInByb2R1Y3RfaWQiOjIxNDc2MzM1MzcsInBvc3RfaWQiOjIxNTE4OTQ0MTF9.1lKWCs-5J4z-q4GYzOqOBJ9wFIgMP4BvGnRrQHMu_II" class="btn post-actions-complete">
              
                Mark As Read
              
            </a>
          </div>
        </div>
      </div>
    </div>
    <div class="post-actions-pagination">
      
        <a href="2151894480.html">
          <i class="fas fa-angle-right"></i>
        </a>
      
    </div>
  </div>
</div>

</div>
  <div class="post-body">
  <div class="main-content-container">
    

    <h1 class="post-body-title">Johnson & Johnson: Single Dose Vaccines?</h1>
    <div data-mobiledoc="{&quot;version&quot;:&quot;0.3.2&quot;,&quot;atoms&quot;:[[&quot;soft-return&quot;,&quot;&quot;,{}],[&quot;soft-return&quot;,&quot;&quot;,{}]],&quot;cards&quot;:[],&quot;markups&quot;:[[&quot;strong&quot;]],&quot;sections&quot;:[[1,&quot;p&quot;,[[0,[0],1,&quot;Stock: &quot;],[0,[],0,&quot;Johnson &amp; Johnson (JNJ) | &quot;],[0,[0],1,&quot;Rating: &quot;],[0,[],0,&quot;Overweight&quot;],[1,[],0,0],[0,[0],1,&quot;Price Target: &quot;],[0,[],0,&quot;$175&quot;],[1,[],0,1],[0,[0],1,&quot;Target Date: &quot;],[0,[],0,&quot;10/2021&quot;]]],[1,&quot;p&quot;,[[0,[0],1,&quot;Headline:&quot;]]],[1,&quot;p&quot;,[[0,[],0,&quot;While companies like Moderna, Pfizer and Astrazeneca have grabbed headlines over the last several months, Johnson &amp; Johnson (JNJ) has also been working on another vaccine. Unlike the three other mentioned above, JNJ" s="" vaccine="" would="" actually="" be="" a="" single="" dose="" we="" believe="" if="" approved="" this="" will="" key="" player="" in="" the="" distribution="" process="" while="" market="" has="" priced="" lot="" of="" general="" upside="" to="" point="" investors="" have="" discounted="" jnj="" contribution="" overall="" solution="" for="" it="" not="" winner="" take="" all="" but="" rather="" blended="" mix="" several="" options="" order="" vaccinate="" world="" as="" quickly="" possible="" 1="" p="" 0="" details:="" when="" looking="" closer="" at="" should="" -="" which="" are="" anticipating="" is="" position="" manufacture="" and="" distribute="" greater="" scale="" than="" any="" other="" provider="" pair="" with="" usage="" potential="" their="" rapidly="" once="" having="" said="" that="" based="" on="" an="" adenovirus="" platform="" calling="" into="" question="" efficacy="" digging="" more="" seen="" ad26="" purposed="" both="" ebola="" zika="" hiv="" demonstrates="" directly="" vector="" applying="" novel="" coronavirus="" however="" what="" ve="" previous="" trials="" could="" 70-90="" range="" these="" numbers="" yet="" been="" finalized="" aware="" expectations="" less="" current="" 2="" solutions="" effective="" given="" global="" shortage="" still="" see="" being="" ordered="" shipped="" also="" closely="" similar="" method="" applied="" via="" spike="" protein="" akin="" moderna="" pfizer="" therefore="" comparisons="" astrazeneca="" unwarranted="" around="" 70="" mark="" may="" safer="" durable="" monitor="" results="" phase="" three="" please="" note="" from="" investing="" standpoint="" healthcare="" advice="" do="" choose="" off="" information="" you="" listen="" your="" public="" health="" officials="" factoring="" implications="" projections="" rolled="" out="" over="" multi-year="" period="" first="" consist="" vaccinations="" end="" pandemic="" second="" vaccines="" treated="" boosters="" newborns="" others="" keep="" bay="" mutations="" virus="" keeping="" immunity="" up="" project="" provide="" financial="" stability="" years="" come="" our="" dcf="" model="" additional="" free="" cash="" flow="" improved="" margins="" boosting="" price="" target="" 175="" overweight="" continue="">
<div>
<p><span style="color: #bacfe7;"><em>Published on December 11, 2020</em></span></p>
<p><strong>Stock: </strong>Johnson &amp; Johnson (JNJ)</p>
<p><strong>Rating: </strong>Overweight</p>
<p><strong>Price Target: </strong>$175</p>
<p><strong>Target Date: </strong>10/2021</p>
<p>&nbsp;</p>
<hr />
<h2>&nbsp;</h2>
<h2><strong>Headline:</strong></h2>
<p>While companies like Moderna, Pfizer and Astrazeneca have grabbed headlines over the last several months, Johnson &amp; Johnson (JNJ) has also been working on another vaccine. Unlike the three other mentioned above, JNJ's vaccine would actually be a single dose! We believe, if approved, this single dose vaccine will be a key player in the distribution process! While the market has priced in a lot of general vaccine upside to this point, we believe investors have discounted JNJ's contribution to the overall solution. For it will not be a winner take all vaccine, but rather a blended mix of several options, in order to vaccinate the world as quickly as possible.</p>
<h2>&nbsp;</h2>
<h2><strong>Details:</strong></h2>
<p>When looking closer at JNJ's vaccine solution, should it be approved - which we are anticipating, we believe JNJ is in a position to manufacture and distribute the vaccine at greater scale than any other provider. Pair this with the single dose usage, and we believe JNJ has the potential to scale their solution rapidly (once approved). Having said that JNJ's solution is based on an adenovirus platform - calling into question their efficacy.</p>
<p>When digging more into the efficacy of their platform, we have seen their Ad26 (adenovirus) platform be purposed for both Ebola, Zika and HIV! This demonstrates directly the potential of their vector in applying this to the novel coronavirus. However, what we've seen in previous trials is that efficacy could be the 70-90% range. While these numbers have not yet been finalized, we are aware that expectations should be less than the current 2 approved solutions. While not as effective, given the global shortage, we still see JNJ's solution being ordered and shipped at global scale.</p>
<p>When also looking more closely at the solution, we see a similar method being applied via the spike protein akin to Moderna &amp; Pfizer. Therefore we believe the comparisons with Astrazeneca are unwarranted and therefore should be more effective (Astrazeneca around the 70% mark). We also believe this solution may be "safer" as we as more durable. This is what we are anticipating, but will monitor the results of their phase three trials.</p>
<blockquote>
<p><span style="color: #06cbf8;"><strong>Please note - We are looking at this from an investing standpoint. This is not healthcare advice. Please do not choose a vaccine, based off of this information. You should still listen to your public health officials.</strong></span></p>
</blockquote>
<p>When factoring in the implications of these projections, we see the vaccine being rolled out over a multi-year period. The first period would consist of global vaccinations at scale, looking to end the pandemic. The second period would be vaccines (treated as boosters) to newborns, and others looking to keep at bay any mutations in the virus and keeping immunity up. Therefore, we project JNJ's solution (if approved) to provide financial stability for years to come. When factoring this into our DCF model, we project out additional free cash flow with improved margins, therefore boosting our price target to $175. We therefore are overweight, and will continue to monitor their trials!</p>
</div>
</div>
    <hr />
  </div>
</div>

  


  <div class="comments">
    <div class="main-content-container">
      
        <form novalidate="novalidate" class="new_comment" id="new_comment" action="https://www.moby.co/posts/2151894411/comments" accept-charset="UTF-8" data-remote="true" method="POST"><input name="utf8" type="hidden" value="✓">
          <div class="media">
            <div>
              <img class="comments-img" src="https://www.gravatar.com/avatar/df42ea502a25d65db01cfd5e62d26643?s=42&d=https://s3.amazonaws.com/kajabi-storefronts-production/static_assets/default_avatar.jpg"/>
            </div>
            <div class="media-body">
              <textarea kjb-settings-id="language_comment_placeholder" rows="5" placeholder="Say Something..." name="comment[body]" id="comment_body" class="form-control"></textarea>
              <input kjb-settings-id="language_comment_add" class="btn comments-btn" type="submit" name="commit" data-disable-with="submitting" value="Post Comment">
            </div>
          </div>
        </form>
      
      
    </div>
  </div>


</div>
<div id="section-post_completion" data-section-id="post_completion">
























<div class="post-completion" data-page="/products/premium-investing-research/categories/2148721380/posts/2151894480" data-counter="10" data-auto="false">
  <div class="post-completion-box">
    <div class="avatar avatar-md avatar-grey avatar-1">
      <img class="avatar-img" src="https://www.gravatar.com/avatar/df42ea502a25d65db01cfd5e62d26643?s=42&d=https://s3.amazonaws.com/kajabi-storefronts-production/static_assets/default_avatar.jpg"/>
    </div>
    <div class="post-completion-box-percent" kjb-settings-id="sections_post_completion_settings_complete_text">1% Complete</div>
    <h4 class="post-completion-box-message" kjb-settings-id="sections_post_completion_settings_message_text">Nice Work, Ilya</h4>
    <p class="post-completion-box-post" kjb-settings-id="sections_post_completion_settings_lesson_text">You just completed the lesson:<br />Johnson & Johnson: Single Dose Vaccines?</p>
    
      <a href="2151894480.html" class="btn post-completion-box-btn" kjb-settings-id="sections_post_completion_settings_next_text">
        Go to Next Lesson
      </a>
    
    <a href="2151894411.html#" class="post-completion-box-cancel" kjb-settings-id="sections_post_completion_settings_cancel_text">Cancel</a>
  </div>
  
</div>


</div>

    <!-- Javascripts ================================================== -->
    <script src="https://kajabi-app-assets.kajabi-cdn.com/assets/core-0664a32a302da74190b5d9deb7357551e8d29b4a22f5c04abbef07d27402c317.js"></script>
    <script charset='ISO-8859-1' src='https://fast.wistia.com/assets/external/E-v1.js'></script>
    <script charset='ISO-8859-1' src='https://fast.wistia.com/labs/crop-fill/plugin.js'></script>
    <script src="https://kajabi-storefronts-production.kajabi-cdn.com/kajabi-storefronts-production/themes/2148837788/assets/scripts.js?1634851986331554"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.3/umd/popper.min.js" integrity="sha384-ZMP7rVo3mIykV+2+9J3UJ46jBk0WLaUAdn689aCwoqbBJiSnjAK/l8WvCWPIPm49" crossorigin="anonymous"></script>
    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.1.3/js/bootstrap.min.js" integrity="sha384-ChfqqxuZUCnJSK3+MXmPNIyE6ZbWh2IMqE241rYiqJxyMiZ6OW/JmZQ5stwEULTy" crossorigin="anonymous"></script>
  </body>
</html>